MARKET

PHVS

PHVS

Pharvaris N.V.
NASDAQ
30.40
-0.30
-0.98%
After Hours: 30.40 0 0.00% 16:13 05/15 EDT
OPEN
30.34
PREV CLOSE
30.70
HIGH
30.44
LOW
29.36
VOLUME
444.23K
TURNOVER
--
52 WEEK HIGH
33.33
52 WEEK LOW
14.59
MARKET CAP
2.11B
P/E (TTM)
-9.5926
1D
5D
1M
3M
1Y
5Y
1D
The Bull Case For Pharvaris (PHVS) Could Change Following Major Equity Raise And NDA Progress - Learn Why
Simply Wall St · 17h ago
Pharvaris price target raised to $33 from $31 at BofA
TipRanks · 2d ago
Pharvaris (PHVS) Receives a Buy from H.C. Wainwright
TipRanks · 3d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Pharvaris (PHVS) and Allogene Therapeutics (ALLO)
TipRanks · 3d ago
Pharvaris Price Target Cut to $74.00/Share From $75.00 by Citizens
Dow Jones · 4d ago
Pharvaris Is Maintained at Market Outperform by Citizens
Dow Jones · 4d ago
Citizens Maintains Market Outperform on Pharvaris, Lowers Price Target to $74
Benzinga · 4d ago
Analysts Are Bullish on Top Healthcare Stocks: Kura Oncology (KURA), Pharvaris (PHVS)
TipRanks · 4d ago
More
About PHVS
Pharvaris NV is a Netherlands-based company primarily engaged in the biopharmaceutical industry. The Company focuses on developing oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks. Their key product is Deucrictibant (PHA121, PHA-022121), which is a small-molecule bradykinin B2 receptor antagonist. It is intended for both the on-demand and prophylactic treatment of HAE attacks. Deucrictibant has been studied in vitro, ex vivo, and in vivo models to assess its effectiveness in blocking the bradykinin B2 receptor. The Company is developing deucrictibant for on-demand use as PHVS416, a softgel capsule, and for prophylactic use as PHVS719, an extended-release tablet.

Webull offers Pharvaris NV stock information, including NASDAQ: PHVS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHVS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHVS stock methods without spending real money on the virtual paper trading platform.